Lakefront Biotherapeutics N.V. (ADR)
General ticker "LKFT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.0B (TTM average)
Lakefront Biotherapeutics N.V. (ADR) does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 1.8%: low 32.90$, high 34.09$
Factors to consider:
- Earnings expected soon, date: nan
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [27.73$, 43.15$]
- 2026-12-31 to 2027-12-31 estimated range: [28.17$, 43.90$]
Short-term LKFT quotes
Long-term LKFT plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | €1,112.25MM |
| Operating Expenses | €610.86MM |
| Operating Income | €501.39MM |
| Non-Operating Income | €-200.52MM |
| Interest Expense | €2.22MM |
| R&D Expense | €459.42MM |
| Income(Loss) | €300.87MM |
| Taxes | €-18.62MM |
| Net Income(Loss)* | €320.88MM |
| Stockholders Equity | €3,235.87MM |
| Inventory | €22.49MM |
| Assets | €3,406.52MM |
| Operating Cash Flow | €-257.46MM |
| Capital expenditure | €13.86MM |
| Investing Cash Flow | €288.81MM |
| Financing Cash Flow | €-3.27MM |
| Earnings Per Share** | €4.87 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.